STANDARD M Point-of-care MDx platform

The STANDARD M Point-of-care MDx platform has been developed to make accurate, simple and faster clinically relevant decisions. Due to its innovative scalable design with a small footprint, the system is extremely flexible to use, in combination with the extremely intuitive software, this ensures easy implementation at any desired location. These unique features ensure that the shortest possible TAT can be achieved with the minimum of hands-on time, with a high degree of ease of use and optimal workflow.


The Alethia® molecular platform addresses your lab’s broad-spectrum needs, simply and accurately, with results in less than an hour for evidence-based health decisions.

Revogene® Carba C

The Revogene Carba C assay provides healthcare systems with a diagnostic solution to enable early detection and management of Carbapenem-Resistant Enterobacteriaceae (CRE) from isolated colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa.


Revogene® is a flexible molecular platform capable of single analyte and multiplex testing that is packaged in a small footprint, and can help standardize testing throughout your health system.

Revogene is a fully automated molecular platform that features single and multiplex testing capabilities with minimal hands-on time. It’s a flexible, scalable platform that is built to grow with you.

Molecular platforms

Mediphos supplies various professional rapid tests, kits and instruments to perform a laboratory test near the patient.

The number of tests performed in the living and / or care environment of the patient has increased considerably in recent years. This so-called Point of Care testing (POCT) is the entire process in support of making a diagnosis, performing the test, interpreting the result, communicating the result and registering a laboratory test performed by an employee in healthcare is provided in the vicinity of the patient during the provision of care.